Ultra Aero Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 09-12-2024
- Revenue 298.82%
(FY 2022)
- Profit 107.99%
(FY 2022)
- Ebitda 189.96%
(FY 2022)
- Net Worth 5.76%
(FY 2022)
- Total Assets -4.44%
(FY 2022)
About Ultra Aero Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 M.
Ravikant Patil, Dhruva Pradhan, Urvashi Pradhan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U99999MH1997PTC105480
- Company No.
105480
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ultra Aero Products?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravikant Patil  | Director | 15-Mar-2011 | Current |
| Dhruva Pradhan | Director | 23-Nov-2021 | Current |
| Urvashi Pradhan | Director | 23-Nov-2021 | Current |
| Abhishek Pradhan | Director | 01-Sep-2018 | Current |
| Chetna Pradhan | Director | 15-Mar-2011 | Current |
Financial Performance of Ultra Aero Products.
Ultra Aero Products Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 298.82% increase. The company also saw a substantial improvement in profitability, with a 107.99% increase in profit. The company's net worth moved up by a moderate rise of 5.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultra Aero Products?
In 2020, Ultra Aero Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eclat Pharma And Aerosols Pvt LtdActive 33 years 5 monthsDhruva Pradhan, Urvashi Pradhan and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 16 May 1997 | ₹1.00 M | Open |
How Many Employees Work at Ultra Aero Products?
Unlock and access historical data on people associated with Ultra Aero Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultra Aero Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Aero Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
